The Disease Activity Score and the EULAR response criteria

Area of Science:

• Rheumatology
• Clinical Trials
• Disease Assessment

Background:

• Rheumatoid arthritis (RA) disease activity is complex and cannot be measured by a single variable.
• The Disease Activity Score (DAS) was developed as a composite index to quantify RA disease activity.
• Assessing treatment efficacy in RA necessitates standardized response criteria.

Purpose of the Study:

• To introduce the Disease Activity Score (DAS) as a comprehensive measure for rheumatoid arthritis.
• To explain the development and application of the European League Against Rheumatism (EULAR) response criteria.
• To outline how EULAR response criteria categorize patient responses in clinical trials.

Main Methods:

• The DAS integrates multiple parameters: swollen joint count, tender joint count, acute phase response, and general health assessment.
• EULAR response criteria are derived from DAS changes and absolute DAS levels achieved.
• These criteria classify patients into non-, moderate, and good responders.

Main Results:

• The DAS provides a composite measure of rheumatoid arthritis disease activity.
• EULAR response criteria enable classification of individual patient responses to treatment.
• Classification depends on both the magnitude of DAS improvement and the final DAS score.

Conclusions:

• The DAS is a crucial tool for assessing rheumatoid arthritis disease activity.
• EULAR response criteria offer a standardized method for evaluating treatment effectiveness in RA clinical trials.
• These tools are essential for consistent and comparable assessment of RA patient outcomes.